Your browser doesn't support javascript.
loading
Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials.
Tinahones, Francisco J; Gallwitz, Baptist; Nordaby, Matias; Götz, Sophia; Maldonado-Lutomirsky, Mario; Woerle, Hans J; Broedl, Uli C.
Affiliation
  • Tinahones FJ; Department of Diabetes, Endocrinology and Nutrition, Instituto de Investigación Biomédica de Málaga (IBIMA) Hospital Universitario Virgen de la Victoria, Universidad Málaga, Málaga, Spain.
  • Gallwitz B; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Málaga, Spain.
  • Nordaby M; Department of Medicine IV (Endocrinology, Diabetes, Angiology, Nephrology & Clinical Chemistry), Eberhard Karls University, Tübingen, Germany.
  • Götz S; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
  • Maldonado-Lutomirsky M; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
  • Woerle HJ; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
  • Broedl UC; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
Diabetes Obes Metab ; 19(2): 266-274, 2017 02.
Article in En | MEDLINE | ID: mdl-27762093
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Benzhydryl Compounds / Diabetes Mellitus, Type 2 / Linagliptin / Glucosides / Hypoglycemic Agents / Metformin Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Benzhydryl Compounds / Diabetes Mellitus, Type 2 / Linagliptin / Glucosides / Hypoglycemic Agents / Metformin Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article